KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021)

Aurinia Pharmaceuticals' Amortization - Intangibles history spans 2 years, with the latest figure at $1.2 million for Q4 2021.

  • For Q4 2021, Amortization - Intangibles changed N/A year-over-year to $1.2 million; the TTM value through Dec 2021 reached $2.8 million, changed N/A, while the annual FY2021 figure was $2.1 million, 61.38% up from the prior year.
  • Amortization - Intangibles reached $1.2 million in Q4 2021 per AUPH's latest filing, up from $517000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $1.2 million in Q4 2021 to a low of $300000.0 in Q1 2020.